ANDA 205043, held by Acs Dobfar Spa. Penicillin G Potassium.
As of Nov 16, 2026, ANDA 205043 (Penicillin G Potassium), held by Acs Dobfar Spa, was first approved by FDA on Oct 26, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2018 | Original application | Approved | None posted |
| Penicillin G Potassium5,000,000 UNITS/VIAL · injectable;injection | Penicillin G Potassium | Rx |
| Penicillin G Potassium20,000,000 UNITS/VIAL · injectable;injection | Penicillin G Potassium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters